Journal of Clinical Microbiology · 2020 · 123 citations · 30 references
Veterinary MedicineInfectious DiseasesMicrobiologyMolecular EpidemiologyMolecular VirologyVirologyRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Tract InfectionsViral GenomicsViral InfectionsChildhood Respiratory Syncytial Virus EpidemiologyMolecular Genetic EpidemiologyPediatric Lower Respiratory Tract Infection EpidemiologyRespiratory Viral InfectionsRespiratory Viral PathogenesisRespiratory Virus SurveillanceRespiratory VirusesViral Respiratory Infections
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection among infants and young children, resulting in annual epidemics worldwide. INFORM-RSV is a multiyear clinical study designed to describe the global molecular epidemiology of RSV in children under 5 years of age by monitoring temporal and geographical evolution of current circulating RSV strains, F protein antigenic sites, and their relationships with clinical features of RSV disease. During the pilot season (2017-2018), 410 RSV G-F gene sequences were obtained from 476 RSV-positive nasal samples collected from 8 countries (United Kingdom, Spain, The Netherlands, Finland, Japan, Brazil, South Africa, and Australia). RSV B (all BA9 genotype) predominated over RSV A (all ON1 genotype) globally (69.0% versus 31.0%) and in all countries except South Africa. Geographic clustering patterns highlighted wide transmission and continued evolution with viral spread. Most RSV strains were from infants of <1 year of age (81.2%), males (56.3%), and patients hospitalized for >24 h (70.5%), with no differences in subtype distribution. Compared to 2013 reference sequences, variations at F protein antigenic sites were observed for both RSV A and B strains, with high-frequency polymorphisms at antigenic site Ø (I206M/Q209R) and site V (L172Q/S173L/K191R) in RSV B strains. The INFORM-RSV 2017-2018 pilot season establishes an important molecular baseline of RSV strain distribution and sequence variability with which to track the emergence of new strains and provide an early warning system of neutralization escape variants that may impact transmission or the effectiveness of vaccines and MAbs under development.
30
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
M. Pamela Griffin, Yuan Yuan, Therese Takas et al. · New England Journal of Medicine · 2020 · 747 citations · Full text
Jason S. McLellan, Yongping Yang, Barney S. Graham et al. · Journal of Virology · 2011 · 428 citations · Full text
ICTV Virus Taxonomy Profile: Pneumoviridae
B. K. Rima, Peter L. Collins, Andrew J. Easton et al. · Journal of General Virology · 2017 · 399 citations · Full text
Michael T. Brady, Carrie L. Byington, H. Dele Davies et al. · PEDIATRICS · 2014 · 390 citations